Desmin – Myotubularin 1 protein–protein interaction (DES-MTM1 PPI)

The Desmin – Myotubularin 1 (MTM1) protein–protein interaction is a critical structural and regulatory nexus in skeletal muscle cells (Hnia et al., 2011, Journal of Cell Science). Desmin, a type III intermediate filament protein, provides a scaffold that integrates the sarcolemma, Z-disks, and nuclear envelope, while MTM1 is a phosphoinositide phosphatase that regulates membrane trafficking (UniProt P17661, Q13323). The physical association between MTM1 and Desmin is essential for the correct assembly and maintenance of the desmin intermediate filament network, which ensures proper organelle positioning, including mitochondria and nuclei (PubMed: 21624955). Disruptions in this interaction, often due to mutations in the MTM1 gene, lead to X-linked myotubular myopathy (XLMTM), characterized by severe muscle weakness and desmin filament disorganization (Amoasii et al., 2012). While no direct small-molecule modulators of this specific interaction are currently in clinical use, therapeutic strategies such as gene replacement therapy (e.g., Resamirigene bilivepvec) aim to restore MTM1 levels and, by extension, the functional complex to improve muscle architecture (ClinicalTrials.gov: NCT03199469). This interaction represents a potential target for stabilizing the muscle cytoskeleton in various centronuclear myopathies.

Other names

Desmin-MTM1 complexMTM1-Desmin interactionDES-MTM1 interaction

Restoration of MTM1 protein levels to facilitate functional interaction with desmin and stabilize the muscle cytoskeleton.